Hyperstable regulation of vigilance in patients with major depressive disorder

World Journal of Biological Psychiatry

Volumn 13, Issue 6, 2012, Pages 436-446

  Hegerl, Ulrich ^a   Wilk, Kathrin ^a   Olbrich, Sebastian ^a   Schoenknecht, Peter ^a   Sander, Christian ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Affective disorders; EEG; Major depressive disorder; VIGALL; Vigilance

Indexed keywords

ADULT; ALERTNESS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MOOD DISORDER; PROSPECTIVE STUDY; SLEEP QUALITY; SLEEP TIME;

ADULT; AROUSAL; BRAIN; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 84857368821     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2011.579164     Document Type: Article

References (73)

1. Bares M, Brunovsky M, Kopecek M, Novak T, Stopkova P, Kozeny J, et al. 2008. Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder. Eur Psychiatry 23:350-355.
2. American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders - DSM-IV-TR. Washington, DC: American Psychiatric Press.
3. Bares M, Brunovsky M, Novak T, Kopecek M, Stopkova P, Sos P, et al. 2010. The change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatments. Eur Neuropsychopharmacol 20:459-466.
4. Bente D. 1964. Die Insuffi zienz des Vigilit ä tstonus. Thesis: Universit ä t Erlangen.
5. Berridge CW, Waterhouse BD. 2003. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 42:33-84.
6. Broughton R, Hasan J. 1995. Quantitative topographic electroencephalographic mapping during drowsiness and sleep onset. J Clin Neurophysiol 12:372-386.
7. Bruder GE, Stewart JW, Tenke CE, McGrath PJ, Leite P, Bhattacharya N, et al. 2001. Electroencephalographic and perceptual asymmetry differences between responders and nonresponders to an SSRI antidepressant. Biol Psychiatry 49:416-425.
8. Bruder GE, Sedoruk JP, Stewart JW, McGrath PJ, Quitkin FM, Tenke CE. 2008. Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment fi ndings. Biol Psychiatry 63:1171-1177.
9. Brundin L, Bj ökqvist M, Petersen A, Tr ä skman-Bendz L. 2007. Reduced orexin levels in the cerebrospinal fl uid of suicidal patients with major depressive disorder, Eur Neuropsychopharmacol 17:573-579.
10. Bschor T, Muller-Oerlinghausen B, Ulrich G. 2001. Decreased level of EEG-vigilance in acute mania as a possible predictor for a rapid effect of methylphenidate: a case study. Clin Electroencephalogr 32:36-39.
11. Cantero JL, Atienza M, Gomez C, Salas RM. 1999. Spectral structure and brain mapping of human alpha activities in different arousal states. Neuropsychobiology 39:110-116.
12. Cantero JL, Atienza M, Salas RM. 2002. Human alpha oscillations in wakefulness, drowsiness period, and REM sleep: different electroencephalographic phenomena within the alphaband. Neurophysiol Clin 32:54-71.
13. Coatanhay A, Soufflet L, Staner L, Boeijinga P. 2002. EEG source identifi cation: frequency analysis during sleep. CR Biol 325: 273-282.
14. Connemann BJ, Mann K, Lange-Asschenfeldt C, Ruchsow M, Schreckenberger M, Bartenstein P, et al. 2005. Anterior limbic alpha-like activity: a low resolution electromagnetic tomography study with lorazepam challenge. Clin Neurophysiol 116:886-894.
15. Cook IA, Leuchter AF, Morgan M, Witte E, Stubbeman WF, Abrams M, et al. 2002. Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology 27:120-131.
16. Cook IA, Hunter AM, Abrams M, Siegman B, Leuchter AF. 2009. Midline and right frontal brain function as a physiologic biomarker of remission in major depression. Psychiatry Res 174:152-157.
17. Davidson RJ, Lewis DA, Alloy LB, Amaral DG, Bush G, Cohen JD, et al. 2002. Neural and behavioral substrates of mood and mood regulation. Biol Psychiatry 52:478-502.
18. De Gennaro L, Ferrara M, Curcio G, Cristiani R. 2001. Antero-posterior EEG changes during the wakefulness-sleep transition. Clin Neurophysiol 112:1901-1911.
19. Delorme A, Sejnowski T, Makeig S. 2007. Enhanced detection of artifacts in EEG data using higher-order statistics and independent component analysis. Neuroimage 34:1443-1449.
20. Feldman-Naim S, Turner EH, Leibenluft E. 1997. Diurnal variation in the direction of mood switches in patients with rapid-cycling bipolar disorder. J Clin Psychiatry 58:79-84.
21. First MB, Spitzer RL, Gibbon M, Williams JBW. 1997. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinical Version. Washington, DC: American Psychiatric Press.
22. Giedke H, Schwarzler F. 2002. Therapeutic use of sleep deprivation in depression. Sleep Med Rev 6:361-377.
23. Görtelmeyer R. 1981. Schlaffragebogen SF-A und SF-B. In: Collegium Internationale Psychiatriae Scalarum (CIPS), editor. Internationale Skalen f ü r Psychiatrie. Weinheim: Beltz.
24. Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
25. Hegerl U, Bottner AC, Holtschmidt-Taschner B, Born C, Seemuller F, Scheunemann W, et al. 2008a. Onset of depressive episodes is faster in patients with bipolar versus unipolar depressive disorder: evidence from a retrospective comparative study. J Clin Psychiatry 69:1075-1080.
26. Hegerl U, Stein M, Mulert C, Mergl R, Olbrich S, Dichgans E, et al. 2008b. EEG-vigilance differences between patients with borderline personality disorder, patients with obsessivecompulsive disorder and healthy controls. Eur Arch Psychiatry Clin Neurosci 258:137-143.
27. Hegerl U, Sander C, Olbrich S, Schoenknecht P. 2009. Are psychostimulants a treatment option in mania? Pharmacopsychiatry 42:169-174.
28. Hegerl U, Himmerich H, Engmann B, Hensch T. 2010. Mania and attention-defi cit/hyperactivity disorder: common symptomatology, common pathophysiology and common treatment? Curr Opin Psychiatry 23:1-7.
29. Holsboer F, Ising M. 2008. Central CRH system in depression and anxiety - evidence from clinical studies with CRH1 receptor antagonists. Eur J Pharmacol 583:350-357.
30. Hunter AM, Cook IA, Leuchter AF. 2007. The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder. Psychiatr Clin North Am 30:105-124.
31. Iber C, Ancoli-Israel S, Chesson A, Quan SFe. 2007. The AASM manual for the scoring of sleep and associated events: rules, terminology, and technical specifi cation. Westchester, IL: American Academy of Sleep Medicine.
32. Iosifescu DV, Greenwald S, Devlin P, Mischoulon D, Denninger JW, Alpert JE, et al. 2009. Frontal EEG predictors of treatment outcome in major depressive disorder. Eur Neuropsychopharmacol 19:772-777.
33. Kaida K, Takahashi M, Akerstedt T, Nakata A, Otsuka Y, Haratani T, et al. 2006. Validation of the Karolinska sleepiness scale against performance and EEG variables. Clin Neurophysiol 117:1574-1581.
34. Kendall MG. 1962. Rank correlation methods. London: Charles Griffin.
35. Klimesch W, Sauseng P, Hanslmayr S. 2007. EEG alpha oscillations: the inhibition-timing hypothesis. Brain Res Rev 53:63-88.
36. Knott V, Mahoney C, Kennedy S, Evans K. 2000. Pre-treatment EEG and it's relationship to depression severity and paroxetine treatment outcome. Pharmacopsychiatry 33:201-205.
37. Knott VJ, Telner JI, Lapierre YD, Browne M, Horn ER. 1996. Quantitative EEG in the prediction of antidepressant response to imipramine. J Affect Disord 39:175-184.
38. Lienert GA. 1973. Verteilungsfreie Methoden in der Biostatistik. Meisenheim am Glan: Anton Hain.
39. Loomis AL, Harvey EN, Horbart GA. 1937. Cerebral states during sleep, as studied by human brain potentials. J Exp Psychol 21:127-144.
40. Manshanden I, De Munck JC, Simon NR, Lopes da Silva FH. 2002. Source localization of MEG sleep spindles and the relation to sources of alpha band rhythms. Clin Neurophysiol 113:1937-1947.
41. Marzano C, Fratello F, Moroni F, Pellicciari MC, Curcio G, Ferrara M, et al. 2007. Slow eye movements and subjective estimates of sleepiness predict EEG power changes during sleep deprivation. Sleep 30:610-616.
42. Niedermeyer E. 1997. Alpha rhythms as physiological and abnormal phenomena. Int J Psychophysiol 26:31-49.
43. Ohno K, Sakurai T. 2008. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness. Front Neuroendocrinol 29:70-87.
44. Olbrich S, Mulert C, Karch S, Trenner M, Leicht G, Pogarell O, et al. 2009. EEG-vigilance and BOLD effect during simultaneous EEG/fMRI measurement. Neuroimage 45: 319-332.
45. Olbrich S, Jödicke J, Sander C, Himmerich H, Hegerl U. 2011. ICA-based muscle artefact correction of EEG data: What is muscle and what is brain? Comment on McMenamin, et al. Neuroimage 54:1-3.
46. Olbrich S, Sander C, Jahn I, Eplinius F, Claus S, Mergl R, et al. 2012. Unstable EEG-vigilance in patients with cancer-related fatigue (CRF) in comparison to healthy controls. World J Biol Psychiatry 13:146-152.
47. Plotsky PM, Owens MJ, Nemeroff CB. 1998. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am 21:293-307.
48. Pollock VE, Schneider LS. 1990. Quantitative, waking EEG research on depression. Biol Psychiatry 27:757-780.
49. Roth B. 1961. The clinical and theoretical importance of EEG rhythms corresponding to states of lowered vigilance. Electroencephalogr Clin Neurophysiol 13:395-399.
50. Sander C, Arns M, Olbrich S, Hegerl U. 2010. EEG-vigilance and response to stimulants in paediatric patients with attention defi cit/hyperactivity disorder. Clin Neurophysiol 121: 1511-1518.
51. Sangal RB, Thomas L, Mitler MM. 1992a. Disorders of excessive sleepiness. Treatment improves ability to stay awake but does not reduce sleepiness. Chest 102:699-703.
52. Sangal RB, Thomas L, Mitler MM. 1992b. Maintenance of wakefulness test and multiple sleep latency test. Measurement of different abilities in patients with sleep disorders. Chest 101:898-902.
53. Saper CB, Scammell TE, Lu J. 2005. Hypothalamic regulation of sleep and circadian rhythms. Nature 437:1257-1263.
54. Schmidt FM, Brügel M, Kratzsch J, Strau ss M, Sander C, Baum P, et al. 2010. Cerebrospinal fl uid hypocretin-1 (orexin A) levels in mania compared to unipolar depression and healthy controls. Neurosci Lett 483:20-22.
55. Schoenknecht P, Olbrich S, Sander C, Spindler P, Hegerl U. 2010. Treatment of acute mania with modafi nil monotherapy. Biol Psychiatry 67:e55 - 57.
56. Schroeder MJ, Barr RE. 2000. An alpha modulation index for electroencephalographic studies using complex demodulation. Med Biol Eng Comput 38:306-310.
57. Shaw JC. 1996. Intention as a component of the alpha-rhythm response to mental activity. Int J Psychophysiol 24:7-23.
58. Small JG, Milstein V, Malloy FW, Medlock CE, Klapper MH. 1999. Clinical and quantitative EEG studies of mania. J Affect Disord 53:217-224.
59. Spronk D, Arns M, Barnett KJ, Cooper NJ, Gordon E. 2011. An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: A pilot study. J Affect Disord 128:41-48.
60. Steiger A, Kimura M. 2010. Wake and sleep EEG provide biomarkers in depression. J Psychiatr Res 44:242-252.
61. Strijkstra AM, Beersma DG, Drayer B, Halbesma N, Daan S. 2003. Subjective sleepiness correlates negatively with global alpha (8 - 12 Hz) and positively with central frontal theta (4 - 8 Hz) frequencies in the human resting awake electroencephalogram. Neurosci Lett 340:17-20.
62. Szabo ST, Blier P. 2001. Response of the norepinephrine system to antidepressant drugs. CNS Spectr 6:679-684.
63. Tsuno N, Shigeta M, Hyoki K, Kinoshita T, Ushijima S, Faber PL, et al. 2002. Spatial organization of EEG activity from alertness to sleep stage 2 in old and younger subjects. J Sleep Res 11:43-51.
64. Ulrich G, Brand K. 1993. Dynamically rigid EEG and subtyping of depressive syndromes. Eur Psychiatry 8:25-34.
65. Ulrich G, Furstenberg U. 1999. Quantitative assessment of dynamic electroencephalogram (EEG) organization as a tool for subtyping depressive syndromes. Eur Psychiatry 14:217-229.
66. Ulrich G, Renfordt E, Zeller G, Frick K. 1984. Interrelation between changes in the EEG and psychopathology under pharmacotherapy for endogenous depression. A contribution to the predictor question. Pharmacopsychiatry 17:178-183.
67. Valentino RJ, Van Bockstaele E. 2008. Convergent regulation of locus coeruleus activity as an adaptive response to stress. Eur J Pharmacol 583:194-203.
68. Van Sweden B. 1986. Disturbed vigilance in mania. Biol Psychiatry 21:311-313.
69. West CH, Ritchie JC, Boss-Williams KA, Weiss JM. 2009. Antidepressant drugs with differing pharmacological actions decrease activity of locus coeruleus neurons. Int J Neuropsychopharmacol 12:627-641.
70. West CH, Ritchie JC, Weiss JM. 2010. Paroxetine-induced increase in activity of locus coeruleus neurons in adolescent rats: implication of a countertherapeutic effect of an antidepressant. Neuropsychopharmacology 35:1653-1663.
71. Wilk K, Hegerl U. 2010. Time of mood switches in ultra-rapid cycling disorder: A brief review. Psychiatry Res 180:1-4.
72. Wu JC, Bunney WE. 1990. The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. Am J Psychiatry 147:14-21.
73. Yü ksel C, Ongü r D. 2010. Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biol Psychiatry 68 785-794.